wrong company, yes the one you are talking about is somewhat more progressed… but I don’t think it’ll get approval anytime soon. Study is too small, only 46 patients. They are banking on the new phase 2 studies with combination therapies.
Check my tag, the company is listed on top. come round for a chat there.
Ann: MSB Annual Financial Results and Operational Progress, page-195
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |